A2 Biotherapeutics, Inc. develops novel cell therapies using its Tmod™ platform to selectively target tumor cells while sparing normal cells in cancer treatment.

Nura Bio Inc. develops neuroprotective therapies for neurological diseases, with a focus on advancing their lead candidate, a brain-penetrant SARM1 inhibitor.

Circle Pharma is a biopharmaceutical company developing cell-permeable macrocycle treatments for cancer and other serious diseases.

Atavistik Bio is a biotech company developing precision allosteric therapeutics for oncology, leveraging proprietary screening technology and AI to discover new treatment sites on proteins or RNA.